Medical Technologies

Repart® PG Intradermal Implant, 1 ml and 2 ml, according to TU 32.50.22-009-29155953-2019

Repart® PG Intradermal Implant, 1 ml and 2 ml, according to TU 32.50.22-009-29155953-2019

Available Variants:

1. Repart® PG Intradermal Implant, 1 ml

  • Intradermal implant Repart® PG, 1.0 ml in a 1.0 ml syringe, manufactured by "Becton Dickinson France S.A.S.", France, Registration No. FSZ 2011/11237, or by "SCHOTT Suisse AG", Switzerland, Registration No. FSZ 2009/04195 – 1 unit
  • BD Hypoint disposable sterile injection needle 27G x 1/2" (0.4 mm x 13 mm), manufactured by "Becton Dickinson Medical (S) Pte Ltd.", Singapore, Registration No. FSZ 2008/03143 – 2 units
  • Instructions for use – 1 unit
  • Peel-off sticker – 4 units

2. Repart® PG Intradermal Implant, 2 ml

  • Intradermal implant Repart® PG, 2.0 ml in a 2.25 ml syringe, manufactured by "Becton Dickinson France S.A.S.", France, Registration No. FSZ 2011/11237, or by "SCHOTT Suisse AG", Switzerland, Registration No. FSZ 2009/04195 – 1 unit
  • BD Hypoint disposable sterile injection needle 27G x 1/2" (0.4 mm x 13 mm), manufactured by "Becton Dickinson Medical (S) Pte Ltd.", Singapore, Registration No. FSZ 2008/03143 – 2 units
  • Instructions for use – 1 unit
  • Peel-off sticker – 4 units

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Repart® PG Intradermal Implant, 1 ml and 2 ml, according to TU 32.50.22-009-29155953-2019, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.

Copyright MAXXmarketing GmbH
JoomShopping Download & Support